Safe Steroid Use in 2026: A UK GP’s Evidence-Based Harm Reduction Guide

Why Harm Reduction Matters for Anabolic Steroid Users

As a GP with over twelve years of clinical experience and a special interest in men’s health, I see patients who use anabolic steroids. Some disclose this voluntarily; others only reveal it when I notice elevated haematocrit, suppressed LH/FSH, or unusual liver enzymes on a routine blood panel. The reality is that anabolic steroid use exists across the UK population, and the most effective thing I can do as a clinician is provide honest, evidence-based harm reduction information rather than categorical refusal to engage with the subject.

This guide is written for adults in the UK who have decided to use or are already using anabolic steroids. Its goal is not to encourage use, but to help those who use reduce the health risks associated with that decision as much as possible.

The Non-Negotiable: Blood Testing Before You Start

Before any anabolic steroid cycle, baseline blood tests are essential. At minimum, you need:

• Full blood count (FBC) — establishes your baseline haematocrit and identifies any pre-existing blood abnormalities
• Liver function tests (LFTs) — critical before oral steroids; ALT and AST should be within normal range
• Testosterone, LH, FSH — confirms your natural hormonal baseline and rules out pre-existing hypogonadism
• Lipid panel — anabolic steroids suppress HDL (‘good’ cholesterol) and raise LDL; your cardiovascular baseline matters
• Blood pressure — hypertension is a significant risk factor that anabolic steroids can worsen

Many UK users obtain private blood tests through services such as Medichecks or Thriva without a GP referral. I would always encourage this over using with no testing at all.

Cardiovascular Risk: The Most Important Safety Concern

The cardiovascular consequences of long-term anabolic steroid use are the aspect I am most concerned about as a clinician. The evidence base, while imperfect, consistently shows that chronic use is associated with left ventricular hypertrophy, accelerated atherosclerosis, and elevated risk of sudden cardiac death. A landmark 2017 study published in Circulation found that long-term steroid users had three times the rate of coronary artery disease compared to non-users matched for age and training status.

Harm reduction measures that materially reduce cardiovascular risk:

• Avoid stacking multiple compounds when possible; single-compound cycles carry lower cardiovascular burden
• Use cardiovascular exercise (aerobic, Zone 2) throughout any cycle to support HDL and cardiac function
• Monitor blood pressure throughout; consider a home monitor. If BP exceeds 140/90 consistently, stop the cycle
• Avoid stimulants (ephedrine, high-dose caffeine, clenbuterol) in combination with androgens
• Keep cycles to 12 weeks or fewer; allow equal or greater time off between cycles

Liver Protection: What the Evidence Actually Supports

Oral C-17 alpha-alkylated steroids (Dianabol, Anadrol, Winstrol, Anavar) impose direct hepatotoxic stress. The most evidence-supported hepatoprotective supplement is TUDCA (tauroursodeoxycholic acid) at 500–750 mg daily. NAC (N-acetyl cysteine) at 600 mg daily and milk thistle (silymarin) are also commonly used, though the evidence base for silymarin in this context is weaker than marketing suggests. LFTs mid-cycle and 4–6 weeks post-cycle are prudent.

PCT: Not Optional

Post Cycle Therapy (PCT) is a medically important protocol, not a discretionary add-on. All anabolic steroids suppress endogenous testosterone production via negative feedback on the hypothalamic-pituitary-gonadal axis. Without PCT, recovery of natural testosterone can take 6–18 months and may be incomplete. The standard UK-accessible PCT protocol uses tamoxifen (Nolvadex) 20 mg/day for 6–8 weeks, with or without clomiphene citrate. HCG prior to PCT (500 IU every other day for 2–3 weeks) can accelerate testicular recovery.

When to See a Doctor

There are situations where you must seek medical attention regardless of whether you’ve disclosed your steroid use: chest pain or palpitations, significant shortness of breath, jaundice (yellowing of skin or eyes), severe mood disturbance, or any sign of infection at an injection site. In these cases, go to your GP or A&E. UK doctors are not permitted to report legal or quasi-legal drug use to the police; clinical confidentiality is protected by GMC guidance.